Virtual trials, COVID-19, & the future
Virtual trials, COVID-19, and the future of the industry As the FDA continues to develop evolving guidelines, our industry has experienced a sudden, paradigm shift towards hybrid and virtual trials, with telemedicine becoming the “norm” for patient interaction across a variety of therapeutic areas. PharPoint is a strong advocate of this approach as an option...
April 21, 2020
No Comments